157 related articles for article (PubMed ID: 33446147)
21. Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body
Yamashita S; Yamamoto H; Nakaichi T; Yoneyama T; Yokoyama K
Ann Nucl Med; 2017 Nov; 31(9):686-695. PubMed ID: 28815414
[TBL] [Abstract][Full Text] [Related]
22. Reduced count pediatric whole-body
Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
[TBL] [Abstract][Full Text] [Related]
23. Reducing Radiation Exposure to Paediatric Patients Undergoing [18F]FDG-PET/CT Imaging.
Kertész H; Beyer T; London K; Saleh H; Chung D; Rausch I; Cal-Gonzalez J; Kitsos T; Kench PL
Mol Imaging Biol; 2021 Oct; 23(5):775-786. PubMed ID: 33846898
[TBL] [Abstract][Full Text] [Related]
24. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
Qi Z; Gates EL; O'Brien MM; Trout AT
Pediatr Radiol; 2018 Feb; 48(2):196-203. PubMed ID: 29080987
[TBL] [Abstract][Full Text] [Related]
25. Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner.
Shinohara Y; Ibaraki M; Matsubara K; Sato K; Yamamoto H; Kinoshita T
Ann Nucl Med; 2024 Feb; 38(2):154-161. PubMed ID: 37989801
[TBL] [Abstract][Full Text] [Related]
26. Reduction of
Sekine T; Delso G; Zeimpekis KG; de Galiza Barbosa F; Ter Voert EEGW; Huellner M; Veit-Haibach P
Radiology; 2018 Jan; 286(1):249-259. PubMed ID: 28914600
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.
Kawashima K; Kato K; Tomabechi M; Matsuo M; Otsuka K; Ishida K; Nakamura R; Ehara S
Br J Radiol; 2016 Jul; 89(1063):20150938. PubMed ID: 27146065
[TBL] [Abstract][Full Text] [Related]
28. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
29. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
30. Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI.
Behr SC; Bahroos E; Hawkins RA; Nardo L; Ravanfar V; Capbarat EV; Seo Y
Mol Imaging Biol; 2018 Jun; 20(3):492-500. PubMed ID: 29192363
[TBL] [Abstract][Full Text] [Related]
31. The assessment of time-of-flight on image quality and quantification with reduced administered activity and scan times in 18F-FDG PET.
Armstrong IS; James JM; Williams HA; Kelly MD; Matthews JC
Nucl Med Commun; 2015 Jul; 36(7):728-37. PubMed ID: 25757197
[TBL] [Abstract][Full Text] [Related]
32. Characterization of continuous bed motion effects on patient breathing and respiratory motion correction in PET/CT imaging.
Meier JG; Erasmus JJ; Gladish GW; Peterson CB; Diab RH; Mawlawi OR
J Appl Clin Med Phys; 2020 Jan; 21(1):158-165. PubMed ID: 31816183
[TBL] [Abstract][Full Text] [Related]
33. Application of the long axial field-of-view PET/CT with low-dose [
Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
[TBL] [Abstract][Full Text] [Related]
34. Optimisation of scan duration and image quality in oncological
van Sluis J; Boellaard R; Dierckx RAJO; van Esch ELM; Croes DA; de Ruijter LK; van de Donk PP; de Vries EGE; Noordzij W; Brouwers AH
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2258-2270. PubMed ID: 36947185
[TBL] [Abstract][Full Text] [Related]
35. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
36. Comparison of maximum likelihood and conventional PET scatter scaling methods for
Bal H; Kiser JW; Conti M; Bowen SL
Med Phys; 2021 Aug; 48(8):4218-4228. PubMed ID: 34013586
[TBL] [Abstract][Full Text] [Related]
37. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of
Sah BR; Ghafoor S; Burger IA; Ter Voert EEGW; Sekine T; Delso G; Huellner M; Dedes KJ; Boss A; Veit-Haibach P
J Nucl Med; 2018 Dec; 59(12):1817-1822. PubMed ID: 29880506
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
Mistry V; Scott JR; Wang TY; Mollee P; Miles KA; Law WP; Hapgood G
Cancer Imaging; 2023 Jan; 23(1):11. PubMed ID: 36694244
[TBL] [Abstract][Full Text] [Related]
40. Pelvic Lymph Node Staging by Combined
Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
